Info@ThinkPinkRocks.com

Shorter washout period during transition from natalizumab supported

A prematurely halted trial provides support for a relatively short washout period when transitioning patients with relapsing–remitting multiple sclerosis from natalizumab to fingolimod.

See more here:
Shorter washout period during transition from natalizumab supported

Share

Leave a Reply